AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

MARCH 7, 2024

In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging. Davin Korstjens is a Senior Market Research Program Manager at IMV Medical Information Division, part of Science and Medicine Group.

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added. Hope added.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JANUARY 8, 2024

These efforts are reflected in the company’s mission to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

Healthcare 93

Healthcare Healthcare Radiation Oncology Radiation 93

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

JANUARY 5, 2024

F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of Nuclear Medicine. To that end, the group enrolled 62 patients with confirmed PDAC at their hospital between August 2021 and February 2023.

Diagnose 119

Diagnose Nuclear Medicine Clinic Imaging 119